NCT02319135View on ClinicalTrials.gov

Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

October 28, 2018

Study Completion Date

October 28, 2019

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Azacitadine

DRUG

Fludarabine

DRUG

Cytarabine

DRUG

Lenograstim

DRUG

Filgastrim

Trial Locations (1)

46026

Hospital Universitari i Politècnic La Fe, Valencia

Sponsors

Collaborators (1)

Dynamic Solutions
All Listed Sponsors
collaborator

Dynamic Solutions

INDUSTRY

lead

PETHEMA Foundation

OTHER

NCT02319135 - Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter